ActivMab®
Antigen Virus

Maximize your chances for success against difficult protein targets.

Vaccinex leverages its ActivMab® Technology to provide a source of native antigen embedded in a viral lipid membrane for antibody discovery.

Vaccinex offers two antigenically distinct poxviruses to maximize specificity for the target antigen. Both the mammalian and the avian poxviruses are compatible with in vivo and in vitro antibody discovery methods.

Our Biosafety Level 1 antigen virions efficiently incorporate multi-pass proteins into their outer membrane and are released into the culture medium.


Contact us for a quote or to learn more about ActivMab® Discovery Services

You can now easily find, order, and purchase Vaccinex’s catalog and custom services on Science Exchange

    Your Name (required)

    Company (required)

    Your Email (required)

    I am interested in learning more about

    Your Message

    Learn more by viewing our On-demand Webinar:
    Antibody Discovery for Challenging Targets Powered by ActivMab® Technology

    Learn more about ActivMab® Technology

    Antigen Virus

    In Vivo Discovery

    In Vitro Discovery

    Protein Optimization